Profile of clinical research subjects in an independent outpatient center;Perfil de sujeitos de pesquisa clínica em um centro ambulatorial independente

Ciencia e Saude Coletiva

Volumn 13, Issue 3, 2008, Pages 1023-1032

  Lacativa, Paulo Gustavo Sampaio ^a   Szrajbman, Miriam ^a   Da Silva, Daniele Argentina Santos Morais ^a   Melazzi, Ana Cláudia Caucegli ^a   De Gregório, Luiz Henrique ^a   Russo, Luis Augusto Tavares ^a  

^a Centro de Pesquisa Hospital   (Brazil)

Author keywords

Clinical trial; Demographic factors; Informed consent; Motivation; Questionnaires

Indexed keywords

EID: 45849102325     PISSN: 14138123     EISSN: 16784561     Source Type: Journal    
DOI: 10.1590/s1413-81232008000300025     Document Type: Article

References (27)

1. Agência Européia de Medicamentos. [acessado 2006 Nov 27]. Disponível em: http://www.emea.eu.int
2. Garrafa V, Prado MM. Mudanças na Declaração de Helsinki: fundamentalismo econômico, imperialismo ético e controle social. Cad Saúde Pública 2001; 17:1489-1496.
3. Declaration of Helsinki 2003. [acessado 2006 Ago 12]. Disponível em: http://www.wma.net/e/policy/17-c_e.html
4. CONEP. Resoluções do Conselho Nacional de Saúde (CNS). [acessado 2006 Set 24]. Disponível em: http://conselho.saude.gov. br/comissao/conep/resolucao.html
5. Beecher HK. Ethics and clinical research. 1966. Bull World Health Organ. 2001; 79:367-372.
6. Norman Fost. Ethical issues in clinical research on fracture prevention in patients with osteoporosis. Journal of Bone and Mineral Research 2003; 18:1110-1115.
7. Nascimento S. Cobaias humanos. Correio Braziliense 2002 Mar 17. [acessado 2006 Out 23]. Disponível em: http://www2.correioweb.com.br/cw/ EDICAO_20020317/pri_tem_170302_12.htm
8. Zoboli ELCP, Fracolli LA. A vulnerabilidade do sujeito de pesquisa: uma abordagem multidimensional. Cadernos de Ética em Pesquisa 2001; 8:20-21.
9. Brasil. Portaria no 675/GM de 30 de março de 2006. Aprova a Carta dos direitos dos Usuários da Saúde, que consolida os direitos e deveres do exercício da cidadania na saúde em todo o país. Diário Oficial da União 2006; 31 mar.
10. Salário-mínimo no Estado do Rio de Janeiro 2006. [acessado 2006 Set 24]. Disponível em: http://www.portalbrasil.net/salariominimo. htm
11. Critério de Classificação Econômica Brasil. ABEP. [acessado 2006 Nov 28]. Disponível em: http://www.abep.org/ codigosguias/ABEP_CCEB.pdf
12. IBGE. Estatísticas Populacionais. [acessado 2006 Nov 27]. Disponível em: http://www.ibge.gov.br/seculoxx/ estatisticas_populacionais.shtm
13. Munoz DR, Fortes PAC. O princípio da autonomia e o Consentimento Livre e Esclarecido. In: Costa SIF, Oselka G, Garrafa V, organizadores. Iniciação à bioética. Brasília: Conselho Federal de Medicina; 1998. p. 53-7.
14. Hossne WS. Consentimento: livre e esclarecido. Cadernos de Ética em Pesquisa 2002; 10:3.
15. Ferguson PR. Information giving in clinical trials: the views of medical researchers. Bioethics 2003; 17:101-111.
16. Coulibaly-Traore D, Msellati P, Vidal L, Ekra CW, Dabis F. The Ditrame (ANRS 049) clinical trial aimed at reducing the mother-child transmission of HIV in Abidjan: participants' understanding of the trial principles. Presse Med 2003; 32:343-350.
17. Ramjee G, Morar NS, Alary M, Mukenge-Tshibaka L, Vuylsteke B, Ettiegne-Traore V, Verapol C. Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world. AIDS 2000; 14:2553-2257.
18. McGrath JW, George K, Svilar G, Ihler E, Mafigiri D, Kabugo M. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr 2001; 27:381-388.
19. Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, Koblin B, Gurwith M, Bartholow B. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005; 39:359-364.
20. Fitzgerald DW, Marotte C, Verdier RI, Johnson Jr WD, Pape JW. Comprehension during informed consent in a less-developed country. Lancet 2002; 360:1301-1302.
21. Matoren GM. The clinical research process in the pharmaceutical industry. London: Marcel Dekker, Inc; 1984.
22. Brindis RG, Sennett C. Physician adherence to clinical practice guidelines: does it really matter? Am Heart J 2003; 145:13-15.
23. Wenger NS, Solomon DH, Roth CP, MacLean CH, Saliba D, Kamberg CJ, Rubenstein LZ, Young RT, Sloss EM, Louie R, Adams J, Chang JT, Venus PJ, Schnelle JF, Shekelle PG. The quality of medical care provided to vulnerable community-dwelling older patients. Annals of Internal Medicine 2003; 139:740-747.
24. Nurgat ZA, Craig W, Campbell NC, Bissett JD, Cassidy J, Nicolson MC. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer.2005; 92:1001-1005.
25. Rojavin MA, Downs P, Shetzline MA, Chilingerian R, Cohard-Radice M. Factors motivating dyspepsia patients to enter clinical research. Contemp Clin Trials 2006; 27:103-111.
26. Schutta KM, Burnett CB. Factors that influence a patient's decision to participate in a phase I cancer clinical trial. Oncol Nurs Forum 2000; 27:1435-1438.
27. Vist GE, Hagen KB, Devereaux P, Bryant D, Kristoffersen DT, Oxman AD. Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate (Cochrane review). The Cochrane Library 2005:2.